Subclavian artery stenting: factors influencing long-term outcome. 2004

Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
Charleston Area Medical Center Health Education and Research Institute, Charleston, West Virginia, USA. mbates@camc.org

This study provides extended follow-up of a nonrandomized series of symptomatic patients who underwent subclavian stent-supported angioplasty (SSA) with emphasis on preprocedure factors that may have influenced outcome. The endpoints of mortality and restenosis were analyzed using backward stepwise logistic regression with the following clinical variables: coronary artery disease, hypertension, hyperlipidemia, smoking, diabetes mellitus, chronic obstructive pulmonary disease, chronic renal insufficiency/failure, and hypothyroidism. Restenosis is reported based on prospective serial noninvasive studies and/or angiography. Mortality was evaluated by retrospective database review and inquiry to the State Department of Health and Human Services' statistical registry in patients who were lost to follow-up. Over a 9-year period (mean follow-up, 36.1 +/- 30.4 months; maximum observation, 109.5 months), 101 stents were placed in 91 consecutive patients (37 male, 54 female). The mean age at intervention was 62.03 +/- 9.3. The procedure was technically successful in 89 patients 97% (mean pre- and postoperative stenosis and pressure gradients were 90.2% +/- 9.4% vs. 3.7% +/- 6.6%, P < 0.001, and 59.9 +/- 35.2 vs. 0 mm Hg, P < 0.001, respectively), with 13 minor complications and no immediate major complications. One patient died of unrelated causes within 30 days. Per Kaplan-Meier method, for years 1 through 5, the rates of overall patency were 96%, 91%, 86%, 77%, and 72%; likewise, overall patient survival was 93%, 88%, 8%4, 81%, and 76%. No clear predictors for restenosis were discovered, although a trend toward higher recurrence was noted in women (18.5% in female vs. and 8.6% in male; P > 0.05), but the same were less likely to die during follow-up (P > 0.001). Also, the presence of hypothyroidism (P = 0.004) and increasing age (P = 0.068) were positively correlated with all-cause mortality. This study suggests that SSA is predictable, safe, and durable. The diagnosis of symptomatic subclavian disease is of prognostic importance, with age and male gender representing important predictors of all-cause long-term mortality. The strong association of increased mortality with hypothyroidism is difficult to discard and raises the question of a yet to be described thyroid steal phenomena.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013348 Subclavian Artery Artery arising from the brachiocephalic trunk on the right side and from the arch of the aorta on the left side. It distributes to the neck, thoracic wall, spinal cord, brain, meninges, and upper limb. Arteries, Subclavian,Artery, Subclavian,Subclavian Arteries

Related Publications

Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
November 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,
Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
January 1997, Hormone research,
Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
May 2008, VASA. Zeitschrift fur Gefasskrankheiten,
Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
January 2014, Transplant international : official journal of the European Society for Organ Transplantation,
Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
January 2006, European heart journal,
Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
December 2008, The Journal of cardiovascular surgery,
Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
August 2002, The Journal of the American Association of Gynecologic Laparoscopists,
Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
July 2000, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,
Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
January 1993, Psychopathology,
Mark C Bates, and Mike Broce, and P Scott Lavigne, and Patrick Stone
September 2002, Coronary artery disease,
Copied contents to your clipboard!